THE US Food and Drug Administration has approved Teva's Ajovy (fremanezumab-vfrm) for the preventive treatment of migraine in adults - the second calcitonin gene-related peptide blocker approval after Aimovig, which was registered here last month (PD 23 Aug 2018).
THE Unleashing the Potential of our Health Workforce – Scope of Practice Review report, released yesterday, confirms barriers to care and inefficiencies in the current health system for pharmacists.
THE Older Persons Advocacy Network (OPAN) has expressed support for the Senate’s recent report on the Aged Care Bill 2024, which aims to prioritise older Australians’ legislative rights.
SOUTH Australia will gain its fourth 24-hour community pharmacy in the outer southern suburbs, following soaring demand seen in the state’s three existing round-the-clock pharmacies launched earlier this year.